Stocktoria
Akebia Therapeutics, Inc. AKBA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-20
Akebia Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 11,638,484 | $11.9M |
| MILLENNIUM MANAGEMENT LLC | 2,384,713 | $3.3M |
| RENAISSANCE TECHNOLOGIES LLC | 1,833,128 | $2.5M |
| AQR CAPITAL MANAGEMENT LLC | 1,792,620 | $2.5M |
| CITADEL ADVISORS LLC | 1,726,367 | $2.4M |
| TWO SIGMA INVESTMENTS, LP | 1,297,801 | $1.8M |
| D. E. Shaw & Co., Inc. | 16,106 | $22,387 |
Source: SEC EDGAR filings · CIK 0001517022 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.